DCT and cutaneous melanoma: In the Tg(Grm1) model, the Dopachrome tautomerase (Dct) promoter controls expression of the metabotropic glutamate receptor to produce both uveal melanoma and cutaneous melanoma (Schiffner et al., 2014).